November 16, 2018

Have the Bulls Returned To Biotech?

Today’s market had a clear bullish inclination, particularly in the overall healthcare sector. The sector ETF XLV was up over +0.90%, but the biotech ETF IBB lagged behind at +0.61%. We saw very strong movement in MRK, which was up over +1.40% and reached a high of $76.10 as of the time this content was created. On the negative side, ACHC was hammered after it was reported that buyout talks with KKR had stalled. The stock was down as low as just above $28.00 per share after opening near $38 at the beginning of the session. Here’s a recap of what happened.

about the author:

Mike Patton

Mike Patton took the leap into the markets beginning as a commodities broker in 2005, where he was responsible for identifying trading opportunities and executing trades on behalf of clients. After years as a broker he made the jump to education by joining the team at Trading Advantage, now Prosper Trading Academy.

Read Similar Articles

March 28, 2024

Wait! There Is An Options Greek Called Rho?

Out of all the Greeks in options trading, Rho is capable of providing uniquely critical insights that others cannot offer. Rho measures an option contract’s susceptibility to changing interest rates. We’ll explain how Rho by defining its specific functions, how interest rates impact options trading, and cover some pertinent scenarios. What is Rho in Options […]

Read Article
March 25, 2024

You Have A Lot Of Options Out There

There are a number of different types of options expiration types.  In the vast majority of our signals, our options will be categorized as “American”-style options.  There are some, like VIX options, that are “European”-style options.  Here’s a quick explanation of both. The term “American style” in relation to options has nothing to do with […]

Read Article
January 4, 2024

Funder Trading Review – Best Prop Trading Firm in 2024?

If you are actively trading in the stock market in 2024, chances are you’ve heard a new buzzword flying around: Prop Trading, short for Proprietary Trading. Whether you’ve tried prop trading or not – or have even heard of it at all – its popularity is quickly growing because it provides everyday traders with a […]

Read Article

Read Similar Articles

https://www.prospertrading.com/exxon-mobil-stock-scotts-bearish-trade-idea-went-up-50/Exxon Mobil Stock: Scott’s Bearish Trade Idea Went Up 50%
December 4, 2025

Exxon Mobil Stock: Scott’s Bearish Trade Idea Went Up 50%

Despite being up almost 18% since April, Exxon Mobil stock (XOM) has seen a lot of ups and downs in 2025. Although XOM has been in an overall uptrend since the spring, Scott Bauer says there’s been a “sell the rally” trend—not just in Exxon Mobil stock—but in the broader oil space. Scott featured Exxon […]

Read Article
https://www.prospertrading.com/straddle-vs-strangle-when-can-each-strategy-offer-unlimited-risk/Straddle vs Strangle: When Can Each Strategy Offer Unlimited Risk?
December 2, 2025

Straddle vs Strangle: When Can Each Strategy Offer Unlimited Risk?

The straddle vs strangle debate has challenged many options traders. What do they mean? How do they work? How much risk in each one? While both strategies have big differences, they also possess some notable similarities… …including trading scenarios where each one can offer unlimited risk. Scott Bauer broke down the straddle vs strangle topic […]

Read Article
https://www.prospertrading.com/eli-lilly-stock-whats-next-for-wall-street-standout/Eli Lilly Stock: What’s Next For “Wall Street Standout”?
November 28, 2025

Eli Lilly Stock: What’s Next For “Wall Street Standout”?

Powered by news of its popular diabetes and weight loss drugs, Eli Lilly stock (LLY) has been on a tear in 2025. The stock is up over 38% this year, whose price crossed $1,000 for the first time ever in November. The big run Eli Lilly stock is on has a lot of traders wondering: […]

Read Article